Victor J. Y.
- Country
- Spain
- Department
- Hematology
Research Overview
- Evaluation of Fitusiran for Bleed Prevention in Patients with Severe Hemophilia A Previously Treated with Emicizumab
- Evaluation of Emicizumab Prophylaxis on Joint Health and Physical Activity in Patients Aged ≥13 to <70 with Severe or Moderate Hemophilia A Without FVIII Inhibitors
- Phase 3 Randomized Study of Bendamustine, Rituximab, and Acalabrutinib in Untreated Mantle Cell Lymphoma
Data & Insights
Has run more than one trial at 72 of 222 partner sites.
Specializations
Coagulopathies and Hemostatic Disorders
Focused on the diagnosis and management of congenital and acquired bleeding disorders, emphasizing factor deficiencies and inhibitor development.
- congenital antithrombin deficiency
- Hemophilia A with inhibitors
- acquired angioedema due to C1 inhibitor deficiency
- perioperative hemostasis in hemophilia
- long‑term prophylaxis strategies
Research integrates laboratory assessment with novel therapeutic agents to improve bleeding control.
Hematologic Malignancies and Transplantation
Investigates acute and chronic leukemias, myelodysplastic syndromes, and lymphoma with emphasis on stem cell transplantation outcomes.
- Acute Myeloid Leukemia
- Myelodysplastic Syndrome
- Chronic Myeloid Leukemia
- Allogeneic hematopoietic stem cell transplant
- graft‑versus‑host disease
Clinical programs aim to refine risk stratification and post‑transplant immunomodulation.
Immune‑Mediated Hematologic Disorders
Targets autoimmune cytopenias and inflammatory hematologic conditions through targeted immunotherapies.
- Immune Thrombocytopenia
- Autoimmune hemolytic anemia
- Idiopathic inflammatory myopathy with hematologic involvement
- Systemic lupus erythematosus‑associated cytopenias
- Therapeutic plasma exchange
Studies evaluate biomarker‑guided treatment algorithms.
Cardiovascular and Thrombotic Complications in Hematology
Examines the interplay between clotting disorders and cardiovascular disease, including anticoagulation management.
- Atrial fibrillation in hemophilia patients
- Thrombotic microangiopathy after transplant
- Anticoagulant reversal in bleeding emergencies
- Venous thromboembolism prophylaxis in oncology
- Cardiovascular risk in patients with chronic anemia
Integrates imaging and coagulation biomarkers to guide therapy.
Rare Metabolic and Genetic Hematologic Conditions
Focuses on ultra‑rare disorders where hematologic manifestations intersect with metabolic pathways.
- Fabry disease with renal involvement
- Hereditary angioedema
- Hemophagocytic lymphohistiocytosis
- Congenital platelet function defects
- X‑linked inhibitor of apoptosis protein deficiency
Collaboration with genetic counseling services supports precision medicine approaches.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.